↓ Skip to main content

Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in…

Overview of attention for article published in European Journal of Pharmaceutics & Biopharmaceutics, February 2019
Altmetric Badge

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice
Published in
European Journal of Pharmaceutics & Biopharmaceutics, February 2019
DOI 10.1016/j.ejpb.2019.02.013
Pubmed ID
Authors

Xue Luan, Kamil Rahme, Zhongcheng Cong, Limei Wang, Yifang Zou, Yan He, Hao Yang, Justin D Holmes, Caitriona M O'Driscoll, Jianfeng Guo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 19%
Student > Ph. D. Student 10 19%
Researcher 7 13%
Student > Bachelor 6 11%
Student > Doctoral Student 2 4%
Other 4 7%
Unknown 15 28%
Readers by discipline Count As %
Chemistry 9 17%
Pharmacology, Toxicology and Pharmaceutical Science 8 15%
Agricultural and Biological Sciences 4 7%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 3 6%
Other 8 15%
Unknown 19 35%